EPAS1 and neurofibromatosis type 1: About 40% of them are detected in the context of neurofibromatosis type I (NF1) genetic syndrome (62); a small number of cases have been reported secondary to mosaic mutations of the hypoxia-inducible factor (HIF) gene HIF2A (63, 64).